SCHEMBL37698

SCHEMBL37698

O=C(O)c1cc2c(c(Cl)c1Cl)C(=O)OC21c2ccc(O)cc2Oc2cc(O)ccc21

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.54
ALDH1A1 P00352 3/20 0.54
BRCA1 P38398 3/20 0.54
HSD17B10 Q99714 3/20 0.54
ALOX12 P18054 2/20 0.54
CYP2C9 P11712 1/20 0.54
ALOX15 P16050 1/20 0.54
FTO Q9C0B1 10/20 0.53
MEN1 O00255 4/20 0.53
KMT2A Q03164 4/20 0.53
TDP1 Q9NUW8 4/20 0.53
MAPT P10636 3/20 0.53
RECQL P46063 3/20 0.53
SMAD3 P84022 2/20 0.53
HTT P42858 2/20 0.53
BLM P54132 2/20 0.53
CYP2C19 P33261 1/20 0.53
PRMT1 Q99873 1/20 0.53
ACE2 Q9BYF1 1/20 0.53
TTR P02766 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17515090 0.89 ALDH1A1 (0.55) HPGDALDH1A1BRCA1HSD17B10ALOX12
SCHEMBL5508223 0.85 SMAD3 (0.38) HPGDALDH1A1BRCA1HSD17B10ALOX12
SCHEMBL3625220 0.85 FTO (0.58) HPGDALDH1A1BRCA1HSD17B10ALOX12
SCHEMBL231207 0.84 ALDH1A1 (0.58) HPGDALDH1A1BRCA1HSD17B10ALOX12
SCHEMBL5665945 0.84 ALDH1A1 (0.58) HPGDALDH1A1BRCA1HSD17B10ALOX12
SCHEMBL1987812 0.83 HPGD (0.54) HPGDALDH1A1BRCA1HSD17B10ALOX12
SCHEMBL7610171 0.83 HPGD (0.51) HPGDALDH1A1BRCA1HSD17B10ALOX12
SCHEMBL7575984 0.82 MAPT (0.60) HPGDALDH1A1BRCA1HSD17B10ALOX12
SCHEMBL213292 0.82 HPGD (0.53) HPGDALDH1A1BRCA1HSD17B10ALOX12
SCHEMBL20832 0.81 ALDH1A1 (0.60) HPGDALDH1A1BRCA1HSD17B10ALOX12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 211 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016133913-A1 FLUORESCENTLY LABELED MOLECULES CONTAINING MODIFIED TRYPTOPHAN SEED RESEARCH AND DEVELOPMENT LLC (US) 2016-08-25 WO claimed
US-9127321-B2 Method of detecting Coccidioides species THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE (US) 2015-09-08 US claimed
WO-2011005821-A1 REDUCTIVE RELEASE PROBES CONTAINING A CHEMOSELECTIVELY CLEAVABLE ALPHA-AZIDOETHER LINKER AND METHODS OF USE THEREOF THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2011-01-13 WO claimed
WO-2001018017-A9 METHODS FOR DETECTING AND ENUMERATING CAMPYLOBACTER JEJUNI IN ENVIRONMENTAL SAMPLES AND FOR IDENTIFYING ANTIBIOTIC-RESISTANT STRAINS UNIV MICHIGAN STATE (US) 2002-09-26 WO claimed
US-6358700-B2 USING FLUORESCENT DYE JAPAN MARINE SCIENCE AND TECHNOLOGY CENTER (JP) 2002-03-19 US claimed
WO-2001018017-A1 METHODS FOR DETECTING AND ENUMERATING CAMPYLOBACTER JEJUNI IN ENVIRONMENTAL SAMPLES AND FOR IDENTIFYING ANTIBIOTIC-RESISTANT STRAINS MICHIGAN STATE UNIVERSITY (US) 2001-03-15 WO claimed
US-20260104343-A1 INFORMATION PROCESSING DEVICE, INFORMATION PROCESSING METHOD, PROGRAM, AND INFORMATION PROCESSING SYSTEM Sony Group Corporation (JP) 2026-04-16 US disclosed
US-12540892-B2 Information processing device, information processing method, program, and information processing system Sony Group Corporation (JP) 2026-02-03 US disclosed
EP-3882603-B1 INFORMATION PROCESSING DEVICE, INFORMATION PROCESSING METHOD, AND COMPUTER PROGRAM SONY GROUP CORP (JP) 2026-01-07 EP disclosed
US-12492380-B2 Methods for the production of hepatocytes FUJIFILM Cellular Dynamics, Inc. (US) 2025-12-09 US disclosed
US-20250362230-A1 FLUORESCENCE INTENSITY CORRECTING METHOD, FLUORESCENCE INTENSITY CALCULATING METHOD, AND FLUORESCENCE INTENSITY CALCULATING APPARATUS SONY CORP (JP) 2025-11-27 US disclosed
US-20250314575-A1 INFORMATION PROCESSING APPARATUS, PARTICLE ANALYSIS APPARATUS, PARTICLE FRACTIONATION APPARATUS, AND INFORMATION PROCESSING METHOD Sony Group Corporation (JP) 2025-10-09 US disclosed
US-12399122-B2 Fluorescence intensity correcting method, fluorescence intensity calculating method, and fluorescence intensity calculating apparatus SONY CORPORATION (JP) 2025-08-26 US disclosed
EP-1163517-A2 METHOD OF SCREENING CANDIDATE COMPOUNDS FOR SUSCEPTIBILITY TO BILIARY EXCRETION UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2001-12-19 EP disclosed
US-20010006803-A1 A METHOD FOR DETECTING OF MICROORGANISMS BY FLUORESCENT STAINING USING HYDROSTATIC PRESSURE JAPAN AGENCY FOR MARINE-EARTH SCIENCE AND TECHNOLOGY (JP) 2001-07-05 US disclosed
EP-1105474-A2 HUMAN GENES AND GENE EXPRESSION PRODUCTS V Chiron Corporation (US) 2001-06-13 EP disclosed
WO-2000055355-A2 METHOD OF SCREENING CANDIDATE COMPOUNDS FOR SUSCEPTIBILITY TO BILIARY EXCRETION UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2000-09-21 WO disclosed
WO-1999058675-A2 HUMAN GENES AND GENE EXPRESSION PRODUCTS V CHIRON CORPORATION (US) 1999-11-18 WO disclosed
EP-0892807-A1 GENE FAMILY ASSOCIATED WITH NEUROSENSORY DEFECTS AXYS PHARMACEUTICALS, INC. (US) 1999-01-27 EP disclosed
WO-1997038004-A1 GENE FAMILY ASSOCIATED WITH NEUROSENSORY DEFECTS AXYS PHARMACEUTICALS, INC. (US) 1997-10-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260104343-A1 INFORMATION PROCESSING DEVICE, INFORMATION PROCESSING METHOD, PROGRAM, AND INFORMATION PROCESSING SYSTEM EXOSC5, BOD1L1, ACIN1 HPGD 4241/4885ALDH1A1 1958/4885BRCA1 43/4885
US-12540892-B2 Information processing device, information processing method, program, and information processing system TLN1, TSN, TMCO1 HPGD 4550/4885ALDH1A1 3566/4885BRCA1 490/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.